AUSTIN, Texas, April 27 /PRNewswire-AsiaNet/ –
Agreement with diagnostic image analysis software developer
to enable earlier disease diagnosis
At the Society for Computer Applications in Radiology’s (SCAR) annual
meeting, Royal Philips Electronics (NYSE: PHG; AEX: PHI) today announced that
it has entered a strategic partnership with EDDA Technology to provide advanced
digital radiography solutions to assist in the detection of lung lesions.
Philips has licensed EDDA Technology’s IQQA-Chest software, which is designed
to help clinicians identify, quantify, evaluate and report pulmonary nodules.
The innovative software will be available as part of the Philips digital
radiography portfolio, providing an integrated hardware and software solution.
By bridging the gap between the clinician’s interpretation based upon
patient-specific knowledge and computer analysis of the information captured by
the X-ray, IQQA-Chest helps clinicians increase their performance while
improving the efficiency for the analysis of each image. In clinical
environments, the solution has been shown to increase the discovery rates of
small nodules up to over 85 percent in comparison to detection without IQQA
assistance, which varies between 35 and 65 percent. The first real-time
interactive diagnostic analysis system, IQQA-Chest integrates advanced computer
analysis technology into the clinicians’ diagnostic process.
"Early diagnosis of diseases such as lung cancer can dramatically improve
the clinical outcome for patients," commented Dr. Peter Reimer, global
marketing director General X-Ray, Philips Medical Systems. "Through our
partnership with EDDA Technology we’re providing clinicians with a new set of
tools to aid in their detection of lung lesions at an early stage. IQQA-Chest
complements our extensive radiography product portfolio and will ultimately
lead to greater diagnostic confidence, resulting in better quality of care for
patients."
"Our partnership with Philips reflects the increasingly important role that
advanced computer assistance plays in the diagnosis of potentially
life-threatening diseases," said Dr. Jian-Zhong Qian, president and CEO of EDDA
Technology. "By combining IQQA-Chest with the broad Philips digital radiography
portfolio clinicians can benefit from a powerful diagnostic solution across a
wide range of equipment types. We are pleased about the strategic alliance with
Philips and look forward to working closely together in future developments of
our innovative solution."
IQQA-Chest will be available in combination with the entire Philips digital
radiography portfolio, including DigitalDiagnost, the company’s
state-of-the-art solution for direct digital radiography. The product will
initially be available in the United States and China where the product has
received regulatory clearance, and will become available in additional
countries from 2007.
A demonstration of IQQA-Chest will be featured at the Philips booth at the
SCAR annual meeting, booth number 623.
IQQA is a registered trademark of EDDA Technology, Inc.
For further information please contact:
Philips:
US
Steve Kelly
Tel: +1 425 487 7479
steve.kelly@philips.com
Europe
Gert van Santen
Tel: +31 40 27 82682
gert.van.santen@philips.com
EDDA Technology:
US
Timothy D. Ketchmark
Tel: +1 609 915 2504
tim.ketchmark@edda-tech.com
China
Xiaolan Zeng
Tel: +86 (21) 6390 7025
xzeng@edda-tech.com
About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG; AEX: PHI) is one
of the world’s biggest electronics companies and Europe’s largest, with sales
of $37.7 billion (EUR 30.4 billion) in 2005. With activities in the three
interlocking domains of healthcare, lifestyle and technology and 161,498
employees in more than 60 countries, it has market leadership positions in
medical diagnostic imaging and patient monitoring, color television sets,
electric shavers, lighting and silicon system solutions. News from Philips is
located at http://www.philips.com/newscenter
About EDDA Technology, Inc.
EDDA Technology, Inc. is a clinical computer solution provider in
diagnostic imaging and analysis. EDDA offers a series of new generation
software products to enable early detection of diseases and to enhance
precision in diagnosis and treatment. EDDA’s goal is to deliver advanced
information analysis technologies that improve clinical workflow and accuracy.
A privately held Delaware corporation, EDDA is headquartered in Princeton
Junction, New Jersey, and has a subsidiary in Shanghai, China. More information
about EDDA is located at http://www.edda-tech.com
SOURCE: EDDA Technology, Inc.
CONTACT: Philips:
US:
Steve Kelly,
+1-425-487-7479,
steve.kelly@philips.com, or
Europe:
Gert van Santen,
+31 40 27 82682,
gert.van.santen@philips.com; or
EDDA Technology:
US:
Timothy D. Ketchmark,
+1-609-915-2504,
tim.ketchmark@edda-tech.com, or
China:
Xiaolan Zeng,
+86 (21) 6390 7025,
xzeng@edda-tech.com
Web site: http://www.philips.com/newscenter
Web site: http://www.edda-tech.com
(PHG)
April 27, 2006
Sorry, comments are closed.